大型抑郁症患者的辅助卢马特:随机,双盲,第三期试验的结果
Suresh Durgam1, Willie R Earley1, Susan G Kozauer1
1Intra-Cellular Therapies, a Johnson & Johnson Company, Bedminster, NJ.
The American journal of psychiatry
|December 1, 2025
概括
作为抗抑郁药物治疗的辅助剂,Lumateperone 42 mg显著改善了患有重大抑郁障碍 (MDD) 的成年人的抑郁症状,这些成年人对先前的治疗反应不足. 治疗一般是安全的,并且耐受性很好.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 大型抑郁症 (MDD) 是全球导致残疾的主要原因.
- 许多患有MDD的患者无法获得标准抗抑郁药疗法 (ADT) 的充分反应.
- 对抗治疗性抑郁症需要新的治疗策略.
研究的目的:
- 评估lumateperone 42 mg作为MDD和ADT反应不足的患者ADT的辅助治疗的疗效和安全性.
- 为了评估lumateperone对抑郁症状严重程度和整体疾病负担的影响.
主要方法:
- 一个3期,随机,双盲,安慰剂对照试验.
- 患有DSM-5定义的MDD和不充分的ADT反应的成年参与者 (18-65岁) 被随机分配给6周的卢马特42毫克+ADT或安慰剂+ADT.
- 主要结局包括蒙哥马利-阿斯伯格抑郁评分表 (MADRS) 和临床全球印象表 (CGI-S) 严重性评分从基线到第43天的变化.
主要成果:
- 与安慰剂和ADT相比,Lumateperone + ADT在43日的MADRS总得分 (LSMD=-4.5,效果大小=-0.56) 和CGI-S得分 (LSMD=-0.5,效果大小=-0.51) 呈现出统计学上显著的改善.
- 患者报告的抑郁症状也得到了显著的改善,用lumateperone + ADT (16项快速清单抑郁症状-自我报告,总得分:LSMD=-2.2,效果大小=-0.45).
- 卢马特佩龙+ADT一般耐受良好,常见的不良事件包括头和昏昏欲睡. 由于不良事件导致的停药率在卢马特佩龙组中较高.
结论:
- 卢马特42毫克作为ADT的辅助剂,在MDD和ADT反应不足的患者中,在抑郁症症状和严重程度方面提供了统计学上显著和临床上有意义的改善.
- 卢马特隆+ADT在这个患者群体中通常是安全的,并且耐受良好.
- 卢马特为患有严重抑郁症的患者提供了潜在的新治疗选择,这些患者对现有疗法没有充分的反应.
相关概念视频
01:23Antidepressant Drugs: MAOIs and Other Agents
761
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
761
01:24Mania and Antimanic Drugs: Overview
522
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
522
01:27Depressive Disorders: MDD and Dysthymia
547
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
547
01:30Electroconvulsive Therapy
771
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
771
01:25Antidepressant Drugs: Overview
1.3K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.3K
01:05Long-term Depression
33.0K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.0K